Nano-X Updates ATM Program: $53.9M Remaining, but Shareholder Approval Needed to Issue All Shares

summarizeSummary

Nano-X Imaging updated its ATM equity program, leaving $53.9 million in capacity, but its authorized shares are insufficient to fulfill the full amount without shareholder approval—a hurdle that could delay or limit capital raising amid acute cash needs.

check_boxKey Events · Financing and Capital Events · NNOX

• ATM Program Update

  A prospectus supplement for the existing $100 million ATM program shows $53.9 million in remaining capacity under the June 2024 sales agreement with Cantor Fitzgerald and Mizuho.

• Share Authorization Shortfall

  At the current stock price of $0.974, the company's authorized share capital is insufficient to issue all remaining ATM shares. Shareholder approval would be required to increase authorized shares, creating a potential bottleneck.

• Going-Concern Backdrop

  The ATM update follows a June 25 going-concern warning and withdrawn 2026 revenue guidance, underscoring the urgency of capital raising to fund operations.

• Dilution Overhang

  If fully utilized at current prices, the $53.9 million ATM could nearly double the outstanding share count, representing substantial dilution for existing holders.

auto_awesomeAnalysis · NNOX · Industrial Applications And Services

A prospectus supplement for Nano-X's existing at-the-market (ATM) program reveals $53.9 million in remaining capacity. The critical wrinkle: at today's price, the company's authorized share capital falls short of what's needed to issue all those shares, meaning shareholder approval would be required to increase the authorized count. Coming just weeks after a going-concern warning and withdrawn guidance, the ATM looks like a survival tool, but the authorization gap introduces execution risk.